U-Blot® Research Grade Nexviazyme/Avalglucosidase alfaCat. No. WA3232Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Nexviazyme/Avalglucosidase alfaCat. No. WA3232
U-Blot® Research Grade NeuradiabCat. No. WA3231
U-Blot® Research Grade NetakimabCat. No. WA3230
U-Blot® Research Grade NesvacumabCat. No. WA3229
U-Blot® Research Grade nesfrotamigCat. No. WA3228
U-Blot® Research Grade NerelimomabCat. No. WA3227
U-Blot® Research Grade NepuvibartCat. No. WA3226
U-Blot® Research Grade NemolizumabCat. No. WA3225
U-Blot® Research Grade nelvutamigCat. No. WA3224
U-Blot® Research Grade NelmastobartCat. No. WA3223
U-Blot® Research Grade NelistotugCat. No. WA3222
U-Blot® Research Grade NeihulizumabCat. No. WA3221